# Treatment Use of Domperidone for Gastroparesis

> **NCT02227927** · — · NO_LONGER_AVAILABLE · sponsor: **Scott Gabbard, MD**

## Conditions studied

- Gastroesophageal Reflux Disease
- GERD
- Gastroparesis

## Interventions

- **DRUG:** Domperidone

## Key facts

- **NCT ID:** NCT02227927
- **Lead sponsor:** Scott Gabbard, MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02227927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02227927, "Treatment Use of Domperidone for Gastroparesis". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT02227927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*